National Philanthropic Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.98M Buy
1,654
+315
+24% +$322K 0.03% 171
2026
Q1
$1.23M Sell
1,339
-62
-4% -$62.9K 0.01% 197
2025
Q4
$1.51M Sell
1,401
-118
-8% -$113K 0.01% 186
2025
Q3
$1.16M Buy
1,519
+554
+57% +$412K 0.01% 174
2025
Q2
$752K Sell
965
-337
-26% -$262K 0.01% 196
2025
Q1
$1.08M Buy
1,302
+311
+31% +$259K 0.02% 161
2024
Q4
$765K Buy
991
+349
+54% +$289K 0.01% 188
2024
Q3
$569K Sell
642
-93
-13% -$83.6K 0.01% 186
2024
Q2
$665K Sell
735
-161
-18% -$129K 0.01% 179
2024
Q1
$697K Sell
896
-660
-42% -$470K 0.02% 181
2023
Q4
$907K Buy
+1,556
New +$908K 0.02% 170

Other funds holding LLY

National Philanthropic Trust's LLY Position: Q2 2026 in Review

National Philanthropic Trust increased its Eli Lilly (LLY) stake by 24% in Q2 2026, buying an estimated $322K and bringing the position to 1,654 shares worth $1.98M. The position accounts for 0.03% of the portfolio, ranked #171.

National Philanthropic Trust first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,431 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • National Philanthropic Trust held 1,654 shares of Eli Lilly worth $1.98M as of Q2 2026.
  • National Philanthropic Trust bought 315 Eli Lilly shares in Q2 2026, an estimated $322K.
  • Eli Lilly made up 0.03% of National Philanthropic Trust's portfolio in Q2 2026, its #171 holding.
  • National Philanthropic Trust first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,431 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on National Philanthropic Trust's 13F filing for Q2 2026, filed 14 Aug 2026.